<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00994474</url>
  </required_header>
  <id_info>
    <org_study_id>LK_06_2009</org_study_id>
    <nct_id>NCT00994474</nct_id>
  </id_info>
  <brief_title>Comparison of Outcome Parameters in Laser Rhytide Treatment</brief_title>
  <official_title>Comparison of Clinical Outcome Parameters, the Patient Benefit Index (PBI) and Patient Satisfaction After Ablative Fractional Laser Treatment of Peri-orbital Rhytides</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laserklinik Karlsruhe</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laserklinik Karlsruhe</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We previously published a comparative split-face study which has shown a significant, albeit
      moderate, effect of ablative fractional laser treatment. While indicating that a single
      session with fractional ablative lasers can be effective in the treatment of peri-orbital
      wrinkles, the trial also revealed substantial disagreement between the different end points
      (profilometry, Fitzpatrick wrinkle score, patient satisfaction). Since the PBI is a
      patient-related index it could not be included in the aforementioned split-face trial; the
      present study therefore attempts to further elucidate the patient-related benefit of a single
      fractional ablative laser treatment session as well as carefully analyse the respective
      correlations between the outcome parameters employed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative measurement of wrinkle depth</measure>
    <time_frame>Before and after treatment (3 months)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fitzpatrick wrinkle score</measure>
    <time_frame>Before and after treatment (3 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient benefit index (PBI)</measure>
    <time_frame>Before and after treatment (3 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1, 3, 6 days and 3 months after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Skin Aging</condition>
  <arm_group>
    <arm_group_label>Fractional carbon dioxide laser treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractional Er:YAG laser treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fractional carbon dioxide laser treatment</intervention_name>
    <description>With the CO2 laser (Fraxel Re:pair, Solta Medical Inc., Hayward, CA), patients received two passes at 15 mJ (1st pass) and 20 mJ (2nd pass), respectively, with a total density of 20 %. We employed 'pin-point bleeding' and serosanguinous exudate as a clinical end point. The pulse duration was 10 msec.</description>
    <arm_group_label>Fractional carbon dioxide laser treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fractional Er:YAG laser treatment</intervention_name>
    <description>The Er:YAG laser (MCL 30 Dermablate, Asclepion Laser Technologies GmbH, Jena, Germany) was used in 4 passes with a total fluence of 60 J/cm² and pulse stacking (6 stacked pulses); the pulse duration was 400 μsec.</description>
    <arm_group_label>Fractional Er:YAG laser treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild to moderate peri-orbital rhytides ('crow's feet') at rest (Class II according to
             Fitzpatrick)

        Exclusion Criteria:

          -  unrealistic expectations

          -  inability to meet follow-up criteria

          -  Fitzpatrick skin phototype &gt;III

          -  coagulation disorders or anti-coagulant treatment

          -  allergy to lidocaine or tetracaine

          -  oral isotretinoin within the last 6 months

          -  any active skin disease within the treatment areas (e.g., psoriasis, cancer, or
             autoimmune disease)

          -  synthetic implants in the treatment area

          -  facial cosmetic procedures affecting the treatment area within the last 6 months

          -  photosensitizing medications (e.g., tetracycline, gold)

          -  history of keloid formation

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Syrus Karsai, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laserklinik Karlsruhe</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Laserklinik Karlsruhe</name>
      <address>
        <city>Karlsruhe</city>
        <zip>D-76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2009</study_first_submitted>
  <study_first_submitted_qc>October 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 14, 2009</study_first_posted>
  <last_update_submitted>October 13, 2009</last_update_submitted>
  <last_update_submitted_qc>October 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christian Raulin/Professor Dr.</name_title>
    <organization>Laserklinik Karlsruhe</organization>
  </responsible_party>
  <keyword>Laser surgery</keyword>
  <keyword>Profilometry</keyword>
  <keyword>Fitzpatrick wrinkle score</keyword>
  <keyword>Patient Benefit Index</keyword>
  <keyword>Patient satisfaction</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

